AFNT-211: A phase1 study of autologous CD4+and CD8+T cells engineered to express a high avidity HLA-A*11:01-restricted, KRAS G12V-specific, transgenic TCR; CD8α/β coreceptor; and a FAS41BB switch receptor in patients with advanced/metastatic solid tumors

被引：0
|
作者：
Mitchell, Shaunica
Khan, Binaish
Payumo, Francis
Chiorean, E. Gabriela
Gahvari, Zhubin
Hecht, J. Randolph
Hurwitz, Michael
Leidner, Rom
Lenz, Heinz-Josef
Pelster, Meredith
Punekar, Salman
Schoenfeld, Adam
Zhao, Dan
Vallaster, Markus
Nagorsen, Dirk
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-CT076
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT076
引用
收藏
页数：2
相关论文
共 5 条
  • [1] AFNT-211: A phase 1 study of autologous CD4+and CD8+T cells engineered to express a high avidity HLA-A*11:01-restricted, KRAS G12V-specific, transgenic TCR, a CD8α/β coreceptor, and a FAS41BB switch receptor in patients with advanced/metastatic solid tumors
    Mitchell, Shaunica
    Khan, Binaish
    Payumo, Francis
    Chiorean, E. Gabriela
    Gahvari, Zhubin
    Hecht, J. Randolph
    Hurwitz, Michael E.
    Leidner, Rom
    Lenz, Heinz-Josef
    Pelster, Meredith
    Punekar, Salman Rafi
    Schoenfeld, Adam Jacob
    Zhao, Dan
    Vallaster, Markus P.
    Nagorsen, Dirk
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] KRAS G12V T CELL RECEPTOR-ENGINEERED T CELLS EXPRESSING THE DURABILITY FAS-41BB SWITCH RECEPTOR EXHIBIT A POTENT, PERSISTENT, COORDINATED CD4/CD8 ANTI-TUMOR RESPONSE IN VITRO AND IN VIVO
    He, Xingyue
    Hoffmann, Michelle
    Liang, Jinsheng
    Qu, Hongjing
    Drain, Allison
    Lam, Hubert
    Oda, Shannon
    Schmitt, Thomas
    Chapuis, Aude
    Greenberg, Philip
    Shapiro, Gary
    Vincent, Loic
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A360 - A360
  • [3] Phase I study of autologous CD8+and CD4+transgenic T cells expressing high-affinity KRAS G12V mutation-specific T cell receptors (FH-A11KRASG12V-TCR) in patients with metastatic pancreatic, colorectal and non-small cell lung cancers with KRAS G12V mutations
    Chiorean, Elena Gabriela
    Coveler, Andrew
    Safyan, Rachael
    Cohen, Stacey
    Lee, Sylvia
    Yeung, Cecilia
    Redman, Mary
    Schmitt, Thomas
    Chapuis, Aude
    Greenberg, Philip D.
    CANCER RESEARCH, 2024, 84 (07)
  • [4] Phase I study of autologous CD8+and CD4+transgenic T cells expressing high-affinity KRAS G12V mutation-specific T cell receptors (FH-A11KRASG12V-TCR) in patients with metastatic pancreatic, colorectal, and non-small cell lung cancers with KRAS G12V mutations.
    Safyan, Rachael A.
    Redman, Mary Weber
    Coveler, Andrew L.
    Cohen, Stacey A.
    Lee, Sylvia
    Yeung, Cecilia
    Schmitt, Thomas
    Chapuis, Aude
    Greenberg, Philip D.
    Chiorean, E. Gabriela
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : TPS792 - TPS792
  • [5] Attamage-A1: Phase I/II study of autologous CD8+and CD4+transgenic t cells expressing high affinity MAGE-A1-specific T-cell receptor (TCR) combined with anti-PD(L)1 in patients with metastatic MAGE-A1 expressing cancer.
    Schweizer, Michael Thomas
    Gooley, Ted
    Lee, Sylvia
    Gwin, William R.
    Dherin, Monica
    Hickner, Megan
    Casserd, Jennifer
    McAfee, Megan
    Schmitt, Thomas
    Yeung, Cecilia C. S.
    Gadi, Vijayakrishna K.
    Chapuis, Aude
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
1